Drug interaction studies between paclitaxel (Taxol) and OC144-093 — A new modulator of MDR in cancer chemotherapy
- 1 June 2002
- journal article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 27 (2) , 119-126
- https://doi.org/10.1007/bf03190426
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- P-Glycoproteins and Multidrug ResistanceAnnual Review of Pharmacology and Toxicology, 1996
- The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions.British Journal of Clinical Pharmacology, 1995
- Reversal of multidrug resistance by verapamil analoguesBiochemical Pharmacology, 1995
- Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapyMolecular Carcinogenesis, 1995
- SDZ PSC 833, A non‐immunosuppressive cyclosporine: Its potency in overcoming P‐glycoprotein‐mediated multidrug resistance of murine leukemiaInternational Journal of Cancer, 1992
- Cyclosporin Metabolism in Human Liver Microsomes and Its Inhibition by Other DrugsBasic & Clinical Pharmacology & Toxicology, 1990
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.Journal of Histochemistry & Cytochemistry, 1989
- Tolbutamide 4‐hydroxylase activity of human liver microsomes: effect of inhibitors.British Journal of Clinical Pharmacology, 1987
- The effect of verapamil on the pharmacokinetics of adriamycinCancer Chemotherapy and Pharmacology, 1986